RCBC²|醫療線上App不用買-HotApp4Game

Evidence is increasing in respect to risk-adapted screening for malignant illnesses continuously. Since 2012 a guideline for lung cancer screening is published by ACCP (American College of Chest Physicians) and ASCO (American Society of Clinical Oncology) with discussion of benefits and harms in prevention. For bladder cancer we have defined risk factors since more than 100 years but preventive care is not an actual duty in urology.With the tool RisikoCheck Blasenkrebs© / RiskCheck Bladder Cancer© we offer a device based instrument that delivers an interactive questionnaire to address two main threatening malignancies (bladder cancer and lung cancer) to identify people under risk and to initiate evidence based preventive care diagnostics by urologists, chest physicians, GP’s and radiologist.Everyone interested can use the tool. The risk assessment is shown on screen and printout. It is no medical advice and do not replace the medical consultation with evaluation and weighting in the medical context. But the printout can be used to start a discussion of preventive care with the physician of your personal choice.Physicians can use the tool in daily office work to initiate preventive care concepts for bladder cancer and lung cancer. For a valid data collection and to handle daily patients with a recall management if indicated a registration with username definition and self-chosen, secure password is necessary. This can be achieved by online registration on the website URL http://www.riskcheck-bladder-cancer.info